Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124649192 | 12464919 | 2 | F | 20160717 | 20160614 | 20160722 | EXP | IL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-37927IL | BOEHRINGER INGELHEIM | 0.00 | F | Y | 80.00000 | KG | 20160722 | MD | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124649192 | 12464919 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG | Y | 22512 | 110 | MG | BID | ||||||
| 124649192 | 12464919 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Y | 22512 | |||||||||||
| 124649192 | 12464919 | 3 | C | FUSID | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | |||||||||
| 124649192 | 12464919 | 4 | C | FUSID | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 40 MG | 0 | 40 | MG | QD | |||||||
| 124649192 | 12464919 | 5 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 13.5 MG | 0 | 13.5 | MG | QD | |||||||
| 124649192 | 12464919 | 6 | C | DEXTROSE-SALINE | 2 | Unknown | STRENGTH: DEXTROSE 5% + 0.45% SALINE 1000 ML | 0 | |||||||||||
| 124649192 | 12464919 | 7 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 5 MG | 0 | 5 | MG | QD | |||||||
| 124649192 | 12464919 | 8 | C | CONTROLOC | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 160 MG | 0 | 40 | MG | QID | |||||||
| 124649192 | 12464919 | 9 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | 320 MG | 0 | 160 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124649192 | 12464919 | 1 | Cerebrovascular accident prophylaxis |
| 124649192 | 12464919 | 2 | Atrial fibrillation |
| 124649192 | 12464919 | 3 | Product used for unknown indication |
| 124649192 | 12464919 | 5 | Product used for unknown indication |
| 124649192 | 12464919 | 6 | Product used for unknown indication |
| 124649192 | 12464919 | 7 | Product used for unknown indication |
| 124649192 | 12464919 | 8 | Product used for unknown indication |
| 124649192 | 12464919 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124649192 | 12464919 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124649192 | 12464919 | Cellulitis | |
| 124649192 | 12464919 | Melaena | |
| 124649192 | 12464919 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124649192 | 12464919 | 3 | 20160512 | 0 |